If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> DERMATOLOGY<br /> ISSN 2054-6211 Vol 6.1 • October 2018 • europeanmedical-journal.com<br /> INSIDE<br /> Review of<br /> EADV 2018<br /> Paris, France<br /> Bring balance to your<br /> psoriasis patients<br /> Skilarence®<br /> dimethyl fumarate<br /> Skilarence® is an oral treatment option for moderate-to-severe plaque psoriasis in adults in need of<br /> systemic therapy.1<br /> A cost-effective choice over apremilast that improves quality of life vs. placebo2,3*<br /> Flexible dosing that allows for a balance between ef cacy and tolerability1<br /> A higher drug survival rate with FAEs compared to methotrexate4†<br /> Skilarence 30 mg & 120 mg gastro-resistant tablets Active<br /> Ingredient: Skilarence 30 mg Each gastro-resistant tablet contains<br /> 30 mg dimethyl fumarate. Also contains 34.2 mg lactose (as<br /> monohydrate). Skilarence 120 mg Each gastro<a title="EMJ Dermatology 6.1 2018 page 1" href="http://viewer.zmags.com/publication/24713a27?page=1"> DERMATOLOGY ISSN 2054-6211 </a> <a title="EMJ Dermatology 6.1 2018 page 2" href="http://viewer.zmags.com/publication/24713a27?page=2"> Bring balance to your psoriasis patients Skil</a> <a title="EMJ Dermatology 6.1 2018 page 3" href="http://viewer.zmags.com/publication/24713a27?page=3"> The only FAE for adults with moderate- t</a> <a title="EMJ Dermatology 6.1 2018 page 4" href="http://viewer.zmags.com/publication/24713a27?page=4"> Contents EDITORIAL BOARD </a> <a title="EMJ Dermatology 6.1 2018 page 5" href="http://viewer.zmags.com/publication/24713a27?page=5"> "A ve</a> <a title="EMJ Dermatology 6.1 2018 page 6" href="http://viewer.zmags.com/publication/24713a27?page=6"> Editorial Board Editor-in-Chief Prof Lawrence F. </a> <a title="EMJ Dermatology 6.1 2018 page 7" href="http://viewer.zmags.com/publication/24713a27?page=7"> Aims and Scope The European Medical Journal (EMJ)</a> <a title="EMJ Dermatology 6.1 2018 page 8" href="http://viewer.zmags.com/publication/24713a27?page=8"> EMJ Dermatol. Chief Executive Officer Spencer Gor</a> <a title="EMJ Dermatology 6.1 2018 page 9" href="http://viewer.zmags.com/publication/24713a27?page=9"> Welcome A very warm welcome to EMJ Dermatology 6.</a> <a title="EMJ Dermatology 6.1 2018 page 10" href="http://viewer.zmags.com/publication/24713a27?page=10"> ® The 3D imaging solution for FACE, BREAST, and </a> <a title="EMJ Dermatology 6.1 2018 page 11" href="http://viewer.zmags.com/publication/24713a27?page=11"> Foreword Dear colleagues, Welcome to the latest e</a> <a title="EMJ Dermatology 6.1 2018 page 12" href="http://viewer.zmags.com/publication/24713a27?page=12"> Confidence starts with clearance b oda umab s n</a> <a title="EMJ Dermatology 6.1 2018 page 13" href="http://viewer.zmags.com/publication/24713a27?page=13"> What does PASI 100 mean to Simon? Kyntheum® is a </a> <a title="EMJ Dermatology 6.1 2018 page 14" href="http://viewer.zmags.com/publication/24713a27?page=14"> ME TRO</a> <a title="EMJ Dermatology 6.1 2018 page 15" href="http://viewer.zmags.com/publication/24713a27?page=15"> Congress Review Review of the European </a> <a title="EMJ Dermatology 6.1 2018 page 16" href="http://viewer.zmags.com/publication/24713a27?page=16"> on Saturday, Dr Elisabeth Grice, Philadelphia, Pe</a> <a title="EMJ Dermatology 6.1 2018 page 17" href="http://viewer.zmags.com/publication/24713a27?page=17"> Improving Social Acceptance for Psoriasis Patient</a> <a title="EMJ Dermatology 6.1 2018 page 18" href="http://viewer.zmags.com/publication/24713a27?page=18"> of sun exposure, independent of skin type. </a> <a title="EMJ Dermatology 6.1 2018 page 19" href="http://viewer.zmags.com/publication/24713a27?page=19"> The EADV argues that current regulations do not g</a> <a title="EMJ Dermatology 6.1 2018 page 20" href="http://viewer.zmags.com/publication/24713a27?page=20"> Basilica of the Sacré-Coeur Landma</a> <a title="EMJ Dermatology 6.1 2018 page 21" href="http://viewer.zmags.com/publication/24713a27?page=21"> "The health authorities do not seem to have </a> <a title="EMJ Dermatology 6.1 2018 page 22" href="http://viewer.zmags.com/publication/24713a27?page=22"> M TRO E </a> <a title="EMJ Dermatology 6.1 2018 page 23" href="http://viewer.zmags.com/publication/24713a27?page=23"> The next milestone in the history of the Hôpital </a> <a title="EMJ Dermatology 6.1 2018 page 24" href="http://viewer.zmags.com/publication/24713a27?page=24"> Quality of Life and Psychosocial Issue in Skin Di</a> <a title="EMJ Dermatology 6.1 2018 page 25" href="http://viewer.zmags.com/publication/24713a27?page=25"> Bridging the Gap Nevertheless, Dr Sampogna does b</a> <a title="EMJ Dermatology 6.1 2018 page 26" href="http://viewer.zmags.com/publication/24713a27?page=26"> It is hoped these kinds of initiatives can help p</a> <a title="EMJ Dermatology 6.1 2018 page 27" href="http://viewer.zmags.com/publication/24713a27?page=27"> See the evidence of long-term CONTROL Rapid an</a> <a title="EMJ Dermatology 6.1 2018 page 28" href="http://viewer.zmags.com/publication/24713a27?page=28"> Interviews Delve into the minds of our dermatol</a> <a title="EMJ Dermatology 6.1 2018 page 29" href="http://viewer.zmags.com/publication/24713a27?page=29"> scientific advances cannot be applied to</a> <a title="EMJ Dermatology 6.1 2018 page 30" href="http://viewer.zmags.com/publication/24713a27?page=30"> You recently published a paper on pemphigoid gest</a> <a title="EMJ Dermatology 6.1 2018 page 31" href="http://viewer.zmags.com/publication/24713a27?page=31"> Dr Simone Ribero  University of Turin, Italy As</a> <a title="EMJ Dermatology 6.1 2018 page 32" href="http://viewer.zmags.com/publication/24713a27?page=32"> "Sunbed use has been reported to increase </a> <a title="EMJ Dermatology 6.1 2018 page 33" href="http://viewer.zmags.com/publication/24713a27?page=33"> of course. I will quote here Patrice Morel</a> <a title="EMJ Dermatology 6.1 2018 page 34" href="http://viewer.zmags.com/publication/24713a27?page=34"> What do you make of the Australian ‘Slip, Slop, S</a> <a title="EMJ Dermatology 6.1 2018 page 35" href="http://viewer.zmags.com/publication/24713a27?page=35"> How important do you feel congress (JD</a> <a title="EMJ Dermatology 6.1 2018 page 36" href="http://viewer.zmags.com/publication/24713a27?page=36"> PASI 90/100, DLQI 0/1, and IL-17 </a> <a title="EMJ Dermatology 6.1 2018 page 37" href="http://viewer.zmags.com/publication/24713a27?page=37"> patients’ perspective on the value of treatment. </a> <a title="EMJ Dermatology 6.1 2018 page 38" href="http://viewer.zmags.com/publication/24713a27?page=38"> 83% (lower limbs).6 This reflects what is seen in </a> <a title="EMJ Dermatology 6.1 2018 page 39" href="http://viewer.zmags.com/publication/24713a27?page=39"> These T cells respond to autoantigens that </a> <a title="EMJ Dermatology 6.1 2018 page 40" href="http://viewer.zmags.com/publication/24713a27?page=40"> IL-17A/F heterodimers (and IL-17A homodimers) sig</a> <a title="EMJ Dermatology 6.1 2018 page 41" href="http://viewer.zmags.com/publication/24713a27?page=41"> Interestingly, IL-17C protein levels are ~100-fol</a> <a title="EMJ Dermatology 6.1 2018 page 42" href="http://viewer.zmags.com/publication/24713a27?page=42"> are ambitious enough to help patients achieve thi</a> <a title="EMJ Dermatology 6.1 2018 page 43" href="http://viewer.zmags.com/publication/24713a27?page=43"> as the anchoring variable, it was achieved for ~8</a> <a title="EMJ Dermatology 6.1 2018 page 44" href="http://viewer.zmags.com/publication/24713a27?page=44"> with psoriasis: Results from BE 38.</a> <a title="EMJ Dermatology 6.1 2018 page 45" href="http://viewer.zmags.com/publication/24713a27?page=45"> Navigating the Road to Psoriasis Control in Women</a> <a title="EMJ Dermatology 6.1 2018 page 46" href="http://viewer.zmags.com/publication/24713a27?page=46"> Prof Augustin discussed the significant impac</a> <a title="EMJ Dermatology 6.1 2018 page 47" href="http://viewer.zmags.com/publication/24713a27?page=47"> cycles and natural menopause (multivariate ha</a> <a title="EMJ Dermatology 6.1 2018 page 48" href="http://viewer.zmags.com/publication/24713a27?page=48"> The amount of time physicians spend listening to </a> <a title="EMJ Dermatology 6.1 2018 page 49" href="http://viewer.zmags.com/publication/24713a27?page=49"> Current therapies include topical treatments </a> <a title="EMJ Dermatology 6.1 2018 page 50" href="http://viewer.zmags.com/publication/24713a27?page=50"> first invited to share their experience regarding </a> <a title="EMJ Dermatology 6.1 2018 page 51" href="http://viewer.zmags.com/publication/24713a27?page=51"> Research has been conducted recently on the level</a> <a title="EMJ Dermatology 6.1 2018 page 52" href="http://viewer.zmags.com/publication/24713a27?page=52"> outpatient clinic: Cohort study. BMJ. 2002;325(73</a> <a title="EMJ Dermatology 6.1 2018 page 53" href="http://viewer.zmags.com/publication/24713a27?page=53"> Is Complete Skin Clearance in Psoriasis the Answe</a> <a title="EMJ Dermatology 6.1 2018 page 54" href="http://viewer.zmags.com/publication/24713a27?page=54"> Prof Reich and Prof Bachelez presented key clinic</a> <a title="EMJ Dermatology 6.1 2018 page 55" href="http://viewer.zmags.com/publication/24713a27?page=55"> p40 </a> <a title="EMJ Dermatology 6.1 2018 page 56" href="http://viewer.zmags.com/publication/24713a27?page=56"> the p40 subunit and inhibits both IL-12 an</a> <a title="EMJ Dermatology 6.1 2018 page 57" href="http://viewer.zmags.com/publication/24713a27?page=57"> Take Home Message Discussion of the pathogenes</a> <a title="EMJ Dermatology 6.1 2018 page 58" href="http://viewer.zmags.com/publication/24713a27?page=58"> Tildrakizumab Tildrakizumab targets the p19 subun</a> <a title="EMJ Dermatology 6.1 2018 page 59" href="http://viewer.zmags.com/publication/24713a27?page=59"> PASI 90 </a> <a title="EMJ Dermatology 6.1 2018 page 60" href="http://viewer.zmags.com/publication/24713a27?page=60"> therapy experience. In patients receiving</a> <a title="EMJ Dermatology 6.1 2018 page 61" href="http://viewer.zmags.com/publication/24713a27?page=61"> (CHAMPION). Br J Dermatol. 2008;158(3):558-66. 7.</a> <a title="EMJ Dermatology 6.1 2018 page 62" href="http://viewer.zmags.com/publication/24713a27?page=62"> IL-23 Inhibition in Psoriasis: Changing the </a> <a title="EMJ Dermatology 6.1 2018 page 63" href="http://viewer.zmags.com/publication/24713a27?page=63"> provide further patient benefit, with focus on the</a> <a title="EMJ Dermatology 6.1 2018 page 64" href="http://viewer.zmags.com/publication/24713a27?page=64"> patients who are affected by psoriasis in d</a> <a title="EMJ Dermatology 6.1 2018 page 65" href="http://viewer.zmags.com/publication/24713a27?page=65"> Modern treatment options provide the </a> <a title="EMJ Dermatology 6.1 2018 page 66" href="http://viewer.zmags.com/publication/24713a27?page=66"> that showed significantly greater ACR 20</a> <a title="EMJ Dermatology 6.1 2018 page 67" href="http://viewer.zmags.com/publication/24713a27?page=67"> IL-23-mediated Th17 pathway.47 In contrast, the </a> <a title="EMJ Dermatology 6.1 2018 page 68" href="http://viewer.zmags.com/publication/24713a27?page=68"> Notably, at the end of the 1-year study, almost h</a> <a title="EMJ Dermatology 6.1 2018 page 69" href="http://viewer.zmags.com/publication/24713a27?page=69"> WATCH THE FULL SYMPOSIUM ONLINE https:/www.youtub</a> <a title="EMJ Dermatology 6.1 2018 page 70" href="http://viewer.zmags.com/publication/24713a27?page=70"> human/003729/WC500183129.pdf. Last accessed: 20 S</a> <a title="EMJ Dermatology 6.1 2018 page 71" href="http://viewer.zmags.com/publication/24713a27?page=71"> From Evolution to Revolution: IL-23 in the Treat</a> <a title="EMJ Dermatology 6.1 2018 page 72" href="http://viewer.zmags.com/publication/24713a27?page=72"> with a maintenance of response in patients with p</a> <a title="EMJ Dermatology 6.1 2018 page 73" href="http://viewer.zmags.com/publication/24713a27?page=73"> allow for the characterisation of a drug’s </a> <a title="EMJ Dermatology 6.1 2018 page 74" href="http://viewer.zmags.com/publication/24713a27?page=74"> by producing IL-22 for as long as 6 years</a> <a title="EMJ Dermatology 6.1 2018 page 75" href="http://viewer.zmags.com/publication/24713a27?page=75"> Finally, in immune surveillance, IL-12 acts </a> <a title="EMJ Dermatology 6.1 2018 page 76" href="http://viewer.zmags.com/publication/24713a27?page=76"> changes in the levels of various members of the </a> <a title="EMJ Dermatology 6.1 2018 page 77" href="http://viewer.zmags.com/publication/24713a27?page=77"> about any long-term effects on these cells,</a> <a title="EMJ Dermatology 6.1 2018 page 78" href="http://viewer.zmags.com/publication/24713a27?page=78"> [IL-23p19/Epstein–Barr virus-induced 3 (Ebi3)] in</a> <a title="EMJ Dermatology 6.1 2018 page 79" href="http://viewer.zmags.com/publication/24713a27?page=79"> Emerging Insights in the Treatment of Psoriasis </a> <a title="EMJ Dermatology 6.1 2018 page 80" href="http://viewer.zmags.com/publication/24713a27?page=80"> Clinical Response After Guselkumab Trea</a> <a title="EMJ Dermatology 6.1 2018 page 81" href="http://viewer.zmags.com/publication/24713a27?page=81"> In VOYAGE 1, 334 patients were initia</a> <a title="EMJ Dermatology 6.1 2018 page 82" href="http://viewer.zmags.com/publication/24713a27?page=82"> To further explore the impact of switching from a</a> <a title="EMJ Dermatology 6.1 2018 page 83" href="http://viewer.zmags.com/publication/24713a27?page=83"> patients in the withdrawal group had PASI 9</a> <a title="EMJ Dermatology 6.1 2018 page 84" href="http://viewer.zmags.com/publication/24713a27?page=84"> work.9 This poster describes the results from a r</a> <a title="EMJ Dermatology 6.1 2018 page 85" href="http://viewer.zmags.com/publication/24713a27?page=85"> guselkumab. Neutropenia was reported in f</a> <a title="EMJ Dermatology 6.1 2018 page 86" href="http://viewer.zmags.com/publication/24713a27?page=86"> Table 1: Gastrointestinal signs and symptoms amon</a> <a title="EMJ Dermatology 6.1 2018 page 87" href="http://viewer.zmags.com/publication/24713a27?page=87"> 4. Reich K et al. Efficacy and safety of </a> <a title="EMJ Dermatology 6.1 2018 page 88" href="http://viewer.zmags.com/publication/24713a27?page=88"> Efficacy, Sustainability, and Patient-Reported </a> <a title="EMJ Dermatology 6.1 2018 page 89" href="http://viewer.zmags.com/publication/24713a27?page=89"> Drug Survival is Superior Among Patients Treated</a> <a title="EMJ Dermatology 6.1 2018 page 90" href="http://viewer.zmags.com/publication/24713a27?page=90"> the association between changes in patient- </a> <a title="EMJ Dermatology 6.1 2018 page 91" href="http://viewer.zmags.com/publication/24713a27?page=91"> Absenteeism and presenteeism data through to </a> <a title="EMJ Dermatology 6.1 2018 page 92" href="http://viewer.zmags.com/publication/24713a27?page=92"> using a manually-operated, patient-controlled,</a> <a title="EMJ Dermatology 6.1 2018 page 93" href="http://viewer.zmags.com/publication/24713a27?page=93"> Mean SIAQ scores for ‘feeling abou</a> <a title="EMJ Dermatology 6.1 2018 page 94" href="http://viewer.zmags.com/publication/24713a27?page=94"> Abstract Reviews Learn from the researchers the</a> <a title="EMJ Dermatology 6.1 2018 page 95" href="http://viewer.zmags.com/publication/24713a27?page=95"> This novel procedure may improve the early </a> <a title="EMJ Dermatology 6.1 2018 page 96" href="http://viewer.zmags.com/publication/24713a27?page=96"> The Influence of Itch and Pain on Sleep in Atopic</a> <a title="EMJ Dermatology 6.1 2018 page 97" href="http://viewer.zmags.com/publication/24713a27?page=97"> inflammatory dermatoses such as AD.8 Results sugge</a> <a title="EMJ Dermatology 6.1 2018 page 98" href="http://viewer.zmags.com/publication/24713a27?page=98"> approach is based on treating the underlying mali</a> <a title="EMJ Dermatology 6.1 2018 page 99" href="http://viewer.zmags.com/publication/24713a27?page=99"> Polymorphic Eruption of Pregnancy with Post</a> <a title="EMJ Dermatology 6.1 2018 page 100" href="http://viewer.zmags.com/publication/24713a27?page=100"> The diagnosis of PEP is mostly clinical, based on</a> <a title="EMJ Dermatology 6.1 2018 page 101" href="http://viewer.zmags.com/publication/24713a27?page=101"> age of the female patients was 38.4±13.3 years an</a> <a title="EMJ Dermatology 6.1 2018 page 102" href="http://viewer.zmags.com/publication/24713a27?page=102"> References 1. Zerbinati N et al. Topical imm</a> <a title="EMJ Dermatology 6.1 2018 page 103" href="http://viewer.zmags.com/publication/24713a27?page=103"> lymphocytes around and within the infundibula of </a> <a title="EMJ Dermatology 6.1 2018 page 104" href="http://viewer.zmags.com/publication/24713a27?page=104"> The recognition of EPDS is of utmost importance t</a> <a title="EMJ Dermatology 6.1 2018 page 105" href="http://viewer.zmags.com/publication/24713a27?page=105"> Figure 1: A 27-year-old secundigravid female, 13 </a> <a title="EMJ Dermatology 6.1 2018 page 106" href="http://viewer.zmags.com/publication/24713a27?page=106"> A 1,000 Anti-alpha gal IgE Ab levels (UA/mL) 10</a> <a title="EMJ Dermatology 6.1 2018 page 107" href="http://viewer.zmags.com/publication/24713a27?page=107"> METHODS A total of 56 patients who presented at S</a> <a title="EMJ Dermatology 6.1 2018 page 108" href="http://viewer.zmags.com/publication/24713a27?page=108"> Beneath the Skin: The Relationship Between</a> <a title="EMJ Dermatology 6.1 2018 page 109" href="http://viewer.zmags.com/publication/24713a27?page=109"> and altered expression of various chemical signal</a> <a title="EMJ Dermatology 6.1 2018 page 110" href="http://viewer.zmags.com/publication/24713a27?page=110"> CAUSING INFLAMMATION PSYCHOLOGICAL DISTRESS Ther</a> <a title="EMJ Dermatology 6.1 2018 page 111" href="http://viewer.zmags.com/publication/24713a27?page=111"> rely on lower-affinity GR to regulate the HPA axi</a> <a title="EMJ Dermatology 6.1 2018 page 112" href="http://viewer.zmags.com/publication/24713a27?page=112"> depressive symptoms correlates significantly wi</a> <a title="EMJ Dermatology 6.1 2018 page 113" href="http://viewer.zmags.com/publication/24713a27?page=113"> who were exposed to IFN and/or IL-2 showed signifi</a> <a title="EMJ Dermatology 6.1 2018 page 114" href="http://viewer.zmags.com/publication/24713a27?page=114"> Systemic inflammation can cause an activation of </a> <a title="EMJ Dermatology 6.1 2018 page 115" href="http://viewer.zmags.com/publication/24713a27?page=115"> psoriatic population leads to the persistence of </a> <a title="EMJ Dermatology 6.1 2018 page 116" href="http://viewer.zmags.com/publication/24713a27?page=116"> 35. Quevedo ME et al. Pleiotropic effects </a> <a title="EMJ Dermatology 6.1 2018 page 117" href="http://viewer.zmags.com/publication/24713a27?page=117"> Psychiatry. 2011;35(3):702-21. 8</a> <a title="EMJ Dermatology 6.1 2018 page 118" href="http://viewer.zmags.com/publication/24713a27?page=118"> A Systematic Review on the Efficacy of Topical </a> <a title="EMJ Dermatology 6.1 2018 page 119" href="http://viewer.zmags.com/publication/24713a27?page=119"> INTRODUCTION Herpes labialis is primarily caused </a> <a title="EMJ Dermatology 6.1 2018 page 120" href="http://viewer.zmags.com/publication/24713a27?page=120"> Articles identified through database searches (N=1</a> <a title="EMJ Dermatology 6.1 2018 page 121" href="http://viewer.zmags.com/publication/24713a27?page=121"> Assessment for Risk of Bias The reviewers evalu</a> <a title="EMJ Dermatology 6.1 2018 page 122" href="http://viewer.zmags.com/publication/24713a27?page=122"> Jensen et al.36 performed a review of oral</a> <a title="EMJ Dermatology 6.1 2018 page 123" href="http://viewer.zmags.com/publication/24713a27?page=123"> 30 August 2018. 8. RxList. Denavir. 2013. Avai</a> <a title="EMJ Dermatology 6.1 2018 page 124" href="http://viewer.zmags.com/publication/24713a27?page=124"> Predicting Response to Omalizumab in Chronic Urti</a> <a title="EMJ Dermatology 6.1 2018 page 125" href="http://viewer.zmags.com/publication/24713a27?page=125"> in patients between the ages of 20 and 40 years; </a> <a title="EMJ Dermatology 6.1 2018 page 126" href="http://viewer.zmags.com/publication/24713a27?page=126"> use and work as an objective follow-up tool for p</a> <a title="EMJ Dermatology 6.1 2018 page 127" href="http://viewer.zmags.com/publication/24713a27?page=127"> The ASST is also associated with autoimmune CU </a> <a title="EMJ Dermatology 6.1 2018 page 128" href="http://viewer.zmags.com/publication/24713a27?page=128"> and induces degranulation of mast cells, while eo</a> <a title="EMJ Dermatology 6.1 2018 page 129" href="http://viewer.zmags.com/publication/24713a27?page=129"> levels of clusterin might be useful in predicting</a> <a title="EMJ Dermatology 6.1 2018 page 130" href="http://viewer.zmags.com/publication/24713a27?page=130"> Arch Allergy Immunol. 2017;172(1): 33. 4</a> <a title="EMJ Dermatology 6.1 2018 page 131" href="http://viewer.zmags.com/publication/24713a27?page=131"> Lingual Pustular Psoriasis and Acrodermatitis Co</a> <a title="EMJ Dermatology 6.1 2018 page 132" href="http://viewer.zmags.com/publication/24713a27?page=132"> BACKGROUND Psoriasis is a well-described derm</a> <a title="EMJ Dermatology 6.1 2018 page 133" href="http://viewer.zmags.com/publication/24713a27?page=133"> A B Figure 1: Psoriatic tongue (A) and </a> <a title="EMJ Dermatology 6.1 2018 page 134" href="http://viewer.zmags.com/publication/24713a27?page=134"> Table 1a: Classification of oral psoriasis.13 Cat</a> <a title="EMJ Dermatology 6.1 2018 page 135" href="http://viewer.zmags.com/publication/24713a27?page=135"> often parallels the clinical course of cutaneous </a> <a title="EMJ Dermatology 6.1 2018 page 136" href="http://viewer.zmags.com/publication/24713a27?page=136"> oral lesions that parallel the clinical course of</a> <a title="EMJ Dermatology 6.1 2018 page 137" href="http://viewer.zmags.com/publication/24713a27?page=137"> Systemic use of the immunomodulator m</a> <a title="EMJ Dermatology 6.1 2018 page 138" href="http://viewer.zmags.com/publication/24713a27?page=138"> pustular psoriasis was achieved, with added </a> <a title="EMJ Dermatology 6.1 2018 page 139" href="http://viewer.zmags.com/publication/24713a27?page=139"> Clinical, histopathological, immunohistochemical </a> <a title="EMJ Dermatology 6.1 2018 page 140" href="http://viewer.zmags.com/publication/24713a27?page=140"> Buyer's Guide > 3GEN, INC. > ABBVIE > ACROSS CO.,</a> <a title="EMJ Dermatology 6.1 2018 page 141" href="http://viewer.zmags.com/publication/24713a27?page=141"> > LABORATOIRES FILORGA > LABORATOIRES MOULIN </a> <a title="EMJ Dermatology 6.1 2018 page 142" href="http://viewer.zmags.com/publication/24713a27?page=142"> Never miss an update again. J</a>